You are here: Industry Insights > SII

News List

Serum Institute obtains DCGI nod to produce Sputnik V vaccine in India pharmaceutical-technology
June 08, 2021
The Drug Controller General of India (DCGI) has granted approval to the Serum Institute of India (SII) to produce Russia’s Covid-19 vaccine, Sputnik V, in the country.
SII gets approval from DCGI to produce Sputnik V vaccine in India expresspharma
June 07, 2021
The firm has collaborated with Gamaleya Research Institute of Epidemiology and Microbiology for developing Sputnik V at its licensed Hadapsar facility.
Will be able to supply 9-10 crore doses of Covishield in June: SII expresspharma
May 31, 2021
In early May, SII had communicated to the Centre that production of Covishield would be ramped up to 6.5 crore in June, seven crore in July and 10 crore each in August and September.
Adar Poonawalla sells stake in Panacea Biotec expresspharma
May 19, 2021
He had a 5.15 per cent shareholding in the company and the total value of the transaction was a little over Rs 118 crores.
SII endorses receiving Rs 1,732 crore for 11 crore doses of Covishield vaccine expresspharma
May 07, 2021
The company's response came after the Health Ministry in a statement refuted the allegations that it has not placed any fresh orders for the Covishield vaccine with SII.
Serum Institute of India to make £240 mn investments in UK expresspharma
May 07, 2021
Serum’s investment will support clinical trials, research and development and possibly manufacturing of vaccines.
Novel vaccine 77 percent effective in preventing malaria, finds study europeanpharmaceuticalreview
April 28, 2021
The R21 vaccine candidate, when administered with 50mg of adjuvant, was found to be 77 percent effective in preventing malaria in children over 12 months.
SII to sell AstraZeneca vaccine to private hospitals at Rs 600 per dose expresspharma
April 23, 2021
We would urge all corporate and private individuals to access the vaccines through the state facilitated machinery and private health systems, said the company.
India approves $610 million grant for Serum Institute, Bharat Biotech to boost vaccine production capacity expresspharma
April 21, 2021
India’s government has approved a 45.67-billion-rupee ($610 million) grant for COVID-19 vaccine makers Serum Institute of India (SII) and Bharat Biotech to boost production capacity as infections spread at record speed, its finance minister said.
SII repays South Africa for COVID-19 vaccines that were not delivered expresspharma
April 12, 2021
The Serum Institute of India has fully refunded South Africa for the 500,000 doses of the COVID-19 vaccine, which were not delivered to the country after it decided not to use the vaccine because it was not effective against a new variant of the virus.

Previous page 1 2 3 4 5 6 Next page